mexiletine has been researched along with Anomalous Ventricular Excitation Syndrome in 8 studies
Mexiletine: Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties.
mexiletine : An aromatic ether which is 2,6-dimethylphenyl ether of 2-aminopropan-1-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Disopyramide was first infused intravenously at 1 mg kg-1 for 5 min followed by a continuous infusion at 0." | 5.28 | Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome. ( Aihara, N; Kamakura, S; Kurita, T; Matsuhisa, M; Ohe, T; Shimizu, W; Shimomura, K; Takaki, H, 1992) |
| "mexiletine did not cause any significant changes in the normal AV conduction pathway; 2." | 5.26 | [Effects of mexiletine in the Wolff-Parkinson-White syndrome]. ( Atallah, G; Gressard, A; Kirkorian, G; Touboul, P, 1981) |
| "Disopyramide was first infused intravenously at 1 mg kg-1 for 5 min followed by a continuous infusion at 0." | 1.28 | Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome. ( Aihara, N; Kamakura, S; Kurita, T; Matsuhisa, M; Ohe, T; Shimizu, W; Shimomura, K; Takaki, H, 1992) |
| "mexiletine did not cause any significant changes in the normal AV conduction pathway; 2." | 1.26 | [Effects of mexiletine in the Wolff-Parkinson-White syndrome]. ( Atallah, G; Gressard, A; Kirkorian, G; Touboul, P, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menozzi, C | 1 |
| Lolli, G | 1 |
| Monducci, I | 1 |
| Gheller, G | 1 |
| Brignole, M | 1 |
| Cattabiani, ML | 1 |
| Vergoni, W | 1 |
| Barone, A | 1 |
| Touboul, P | 1 |
| Gressard, A | 1 |
| Kirkorian, G | 1 |
| Atallah, G | 1 |
| Neumann, G | 1 |
| Grube, E | 1 |
| Funke, H | 1 |
| Perrenoud, JJ | 1 |
| Coumel, P | 1 |
| Krikler, D | 1 |
| Rosen, MR | 1 |
| Wellens, HJ | 1 |
| Zipes, DP | 1 |
| McComish, M | 1 |
| Kitson, D | 1 |
| Robinson, C | 1 |
| Jewitt, DE | 1 |
| Shimizu, W | 1 |
| Ohe, T | 1 |
| Kurita, T | 1 |
| Takaki, H | 1 |
| Aihara, N | 1 |
| Kamakura, S | 1 |
| Matsuhisa, M | 1 |
| Shimomura, K | 1 |
| Róna, G | 1 |
1 review available for mexiletine and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
[Utilization of anti-arrhythmic drugs].
Topics: Action Potentials; Ajmaline; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Digital | 1980 |
7 other studies available for mexiletine and Anomalous Ventricular Excitation Syndrome
| Article | Year |
|---|---|
[Antiarrhythmic efficacy of mexiletine in supraventricular arrhythmias, Wolff-Parkinson-White syndrome and persistent iterative ventricular hyperkinetic arrhythmias. Considerations on these less noted therapeutic effects].
Topics: Adult; Aged; Arrhythmias, Cardiac; Child; Drug Evaluation; Female; Humans; Male; Mexiletine; Middle | 1984 |
[Effects of mexiletine in the Wolff-Parkinson-White syndrome].
Topics: Adult; Female; Heart Conduction System; Humans; Male; Mexiletine; Propylamines; Wolff-Parkinson-Whit | 1981 |
[The value of antitachycardia pacemaker therapy in patients with Wolff-Parkinson-White syndrome].
Topics: Anti-Arrhythmia Agents; Bundle of His; Digitalis Glycosides; Disopyramide; Electrocardiography; Huma | 1983 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Ca | 1978 |
Clinical electrophysiological effects of mexiletine.
Topics: Adolescent; Adult; Aged; Coronary Disease; Depression, Chemical; Female; Heart Conduction System; Hu | 1977 |
Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome.
Topics: Adult; Atrial Fibrillation; Cardiac Pacing, Artificial; Disopyramide; Dose-Response Relationship, Dr | 1992 |
[Treatment of atrial fibrillation with mexiletine in Wolff-Parkinson-White syndrome].
Topics: Adult; Aged; Atrial Fibrillation; Cardiac Pacing, Artificial; Combined Modality Therapy; Electrocard | 1986 |